Matches in Wikidata for { <http://www.wikidata.org/entity/Q40233559> ?p ?o ?g. }
- Q40233559 description "2007 nî lūn-bûn" @default.
- Q40233559 description "2007年の論文" @default.
- Q40233559 description "2007年論文" @default.
- Q40233559 description "2007年論文" @default.
- Q40233559 description "2007年論文" @default.
- Q40233559 description "2007年論文" @default.
- Q40233559 description "2007年論文" @default.
- Q40233559 description "2007年论文" @default.
- Q40233559 description "2007年论文" @default.
- Q40233559 description "2007年论文" @default.
- Q40233559 description "2007年论文" @default.
- Q40233559 description "2007年论文" @default.
- Q40233559 description "2007年论文" @default.
- Q40233559 description "2007년 논문" @default.
- Q40233559 description "article científic" @default.
- Q40233559 description "article scientific" @default.
- Q40233559 description "article scientifique" @default.
- Q40233559 description "articol științific" @default.
- Q40233559 description "articolo scientifico" @default.
- Q40233559 description "artigo científico" @default.
- Q40233559 description "artigo científico" @default.
- Q40233559 description "artigo científico" @default.
- Q40233559 description "artikel ilmiah" @default.
- Q40233559 description "artikull shkencor" @default.
- Q40233559 description "artikulong pang-agham" @default.
- Q40233559 description "artykuł naukowy" @default.
- Q40233559 description "artículo científico publicado en 2007" @default.
- Q40233559 description "artículu científicu espublizáu en 2007" @default.
- Q40233559 description "bilimsel makale" @default.
- Q40233559 description "bài báo khoa học" @default.
- Q40233559 description "naučni članak" @default.
- Q40233559 description "scienca artikolo" @default.
- Q40233559 description "scientific article published on March 2007" @default.
- Q40233559 description "scientific article published on March 2007" @default.
- Q40233559 description "scientific article published on March 2007" @default.
- Q40233559 description "teaduslik artikkel" @default.
- Q40233559 description "tieteellinen artikkeli" @default.
- Q40233559 description "tudományos cikk" @default.
- Q40233559 description "vedecký článok" @default.
- Q40233559 description "vetenskaplig artikel" @default.
- Q40233559 description "videnskabelig artikel" @default.
- Q40233559 description "vitenskapelig artikkel" @default.
- Q40233559 description "vitskapeleg artikkel" @default.
- Q40233559 description "vědecký článek" @default.
- Q40233559 description "wetenschappelijk artikel" @default.
- Q40233559 description "wissenschaftlicher Artikel" @default.
- Q40233559 description "επιστημονικό άρθρο" @default.
- Q40233559 description "мақолаи илмӣ" @default.
- Q40233559 description "наукова стаття, опублікована в березні 2007" @default.
- Q40233559 description "научна статия" @default.
- Q40233559 description "научная статья" @default.
- Q40233559 description "научни чланак" @default.
- Q40233559 description "научни чланак" @default.
- Q40233559 description "מאמר מדעי" @default.
- Q40233559 description "مقالة علمية نشرت في مارس 2007" @default.
- Q40233559 description "মার্চ ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q40233559 description "บทความทางวิทยาศาสตร์" @default.
- Q40233559 description "სამეცნიერო სტატია" @default.
- Q40233559 name "Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma" @default.
- Q40233559 name "Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma" @default.
- Q40233559 type Item @default.
- Q40233559 label "Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma" @default.
- Q40233559 label "Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma" @default.
- Q40233559 prefLabel "Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma" @default.
- Q40233559 prefLabel "Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma" @default.
- Q40233559 P1433 Q40233559-9A2B7626-6E11-41D7-A4B2-0DB9854BB25A @default.
- Q40233559 P1476 Q40233559-B6815BDF-C388-4970-A6CB-ACD9C82F5C30 @default.
- Q40233559 P2093 Q40233559-052EA604-D211-45B9-8BEA-24E1E8619236 @default.
- Q40233559 P2093 Q40233559-06D5F13C-190E-4904-9711-FACBB10FB8E3 @default.
- Q40233559 P2093 Q40233559-230D751F-CE1F-409B-AE2B-28DBD3898BF4 @default.
- Q40233559 P2093 Q40233559-97CA80EE-7C13-4E96-8AA8-D4685A020E8B @default.
- Q40233559 P2093 Q40233559-B277466A-00B4-4C81-8EA1-C12906EE1FFF @default.
- Q40233559 P2093 Q40233559-B9B591CA-294D-4D9B-BEE2-BCB7DE31E360 @default.
- Q40233559 P2093 Q40233559-ED78F067-2A29-4F34-8D3D-A7E1C2A5E1C8 @default.
- Q40233559 P304 Q40233559-7357A7D7-50C0-4F7A-ACC4-AB3C63D3808E @default.
- Q40233559 P31 Q40233559-7202C6D1-DDCC-4DDD-9447-451452C4598C @default.
- Q40233559 P356 Q40233559-4E451A98-22FA-44DD-BE3B-B65539627CBF @default.
- Q40233559 P407 Q40233559-C9A30445-309A-4CEE-9290-C4FBA78C700A @default.
- Q40233559 P433 Q40233559-0B9B25FF-3D79-465B-930C-3EC2BD4C5506 @default.
- Q40233559 P478 Q40233559-DDD61F3A-168C-4F4E-BB22-288182E4A523 @default.
- Q40233559 P50 Q40233559-54058DEC-1F0B-4527-A66D-2D6ED26770CA @default.
- Q40233559 P50 Q40233559-614D4A47-647F-42D0-9CB2-83D180BECC91 @default.
- Q40233559 P50 Q40233559-85BD6A5E-8D11-4909-81DC-BFEF5D2B3AC4 @default.
- Q40233559 P50 Q40233559-B42FEF03-20DB-4ED5-9AB3-F00AB21E5929 @default.
- Q40233559 P50 Q40233559-C8488D7C-CFB9-43CA-BF23-F3872E355F89 @default.
- Q40233559 P50 Q40233559-F70D28E2-5930-409A-ADEE-2522BAFE6E9B @default.
- Q40233559 P577 Q40233559-50B629AB-5840-44F8-A4A2-173F7D34A03C @default.
- Q40233559 P698 Q40233559-3365726C-25FB-46A9-8D42-553EB0B810DD @default.
- Q40233559 P921 Q40233559-1D7046F0-9ED2-46FC-B0A4-CDF4F6E02EBA @default.
- Q40233559 P921 Q40233559-C4659E36-FCB5-4A7E-96E4-D6D1596FD16F @default.
- Q40233559 P921 Q40233559-DC7C8BBF-135A-4D86-AA55-99EB6BCE79EE @default.
- Q40233559 P356 1078-0432.CCR-06-1432 @default.
- Q40233559 P698 17363536 @default.
- Q40233559 P1433 Q332253 @default.
- Q40233559 P1476 "Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma" @default.
- Q40233559 P2093 "Eric Brendel" @default.
- Q40233559 P2093 "Eric Zafarana" @default.
- Q40233559 P2093 "Jean Charles Soria" @default.
- Q40233559 P2093 "Jean-Pierre Armand" @default.
- Q40233559 P2093 "Linda Chami" @default.